Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, mul
about
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, mul
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Adverse drug reactions after i ...... ults from a retrospective, mul
@en
Adverse drug reactions after i ...... ults from a retrospective, mul
@nl
type
label
Adverse drug reactions after i ...... ults from a retrospective, mul
@en
Adverse drug reactions after i ...... ults from a retrospective, mul
@nl
prefLabel
Adverse drug reactions after i ...... ults from a retrospective, mul
@en
Adverse drug reactions after i ...... ults from a retrospective, mul
@nl
P2093
P2860
P50
P1433
P1476
Adverse drug reactions after i ...... ults from a retrospective, mul
@en
P2093
Angela Padula
Anna Passarelli
Fiorella D'Auria
Giacomo Loseto
Giovanni Di Minno
Idanna Innocenti
Luca Laurenti
Marco Tucci
Maria Luigia Vigliotti
Michele Cimminiello
P2860
P304
P356
10.1080/10428194.2017.1306648
P577
2017-04-03T00:00:00Z